# Neuroimaging Biomarkers for Predicting rTMS Response in OCD

> **NCT04286126** · NA · UNKNOWN · sponsor: **Stanford University** · enrollment: 180 (estimated)

## Conditions studied

- Obsessive-Compulsive Disorder

## Interventions

- **DEVICE:** Active bilateral DMPFC
- **DEVICE:** Active right-sided OFC

## Key facts

- **NCT ID:** NCT04286126
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-15
- **Primary completion:** 2025-07-15
- **Final completion:** 2025-12-15
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2023-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04286126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04286126, "Neuroimaging Biomarkers for Predicting rTMS Response in OCD". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04286126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*